MALDI Biodesix Prices $72M IPO Shares of the Boulder, Colorado-based firm will begin trading on the Nasdaq today under ticker symbol "BDSX" at $18 per share. Biodesix, MRM Proteomics Partner on Lung Cancer Assays Under the agreement, MRM Proteomics has granted Biodesix rights to use its iMALDI mass spectrometry technologies to develop blood-based tests for lung cancer. BioMérieux Gets FDA Approval for Expanded Vitek MS Rapid Pathogen Identification The platform received 510(k) clearance from the US Food and Drug Administration for the expanded identification of mycobacteria, Nocardia, and molds. At Clinical Mass Spec Meeting, Ion Mobility, Dried Blood Spots, Cardiac Biomarkers Vie for Attention Premium Multi-omics, mass spec-based imaging, and cardiovascular biomarkers received extra attention at MSACL US while small molecules continue to drive the field. Life Science Mass Spec Posts Solid Q3 Driven by Academic, Pharma Spending Premium Mass spec instrumentation showed solid growth in Q3, with particular strength in academic and government markets. Nov 9, 2012 MALDI, Other Surface Sampling Methods Continue to Make Inroads in Clinical, Quantitative Proteomics Premium Mar 22, 2012 Shimadzu, Sony DADC Extend MALDI Collaboration Jun 11, 2010 Recent Patents of Interest in Proteomics: Jun 11, 2010 Premium May 28, 2010 New Products: May 28, 2010 Premium Oct 9, 2009 MALDI-Based Method May Reduce Cost of Rx-Screening Assays, Speed Drug Development Premium Sep 21, 2009 Bruker Receives New Biotyper Accreditations Sep 15, 2009 German Lab Network to Use Bruker Biotyper Jul 16, 2009 Researchers Find Recurring Proteins in Biomarker Studies Due to Cellular Stress Premium Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.